Rx required · Once weekly
Semaglutide
Proven GLP-1 medication for effective weight management
Starting at $109/mo
Discreet shipping. All-in pricing with no consultation charges.

Pricing
Semaglutide Pricing
All-in pricing. No hidden fees. No "consultation charges." Just what you see.
Every RespondWell Plan Includes:
- Free Provider Consultation
- Medication & supplies
- Free 2-day shipping
- Ongoing medical support
LegitScript Certified- 🔥Starter Dose Launch Special: First order for only $110, future refills at regular price ($160)

Treatment that fits the way you actually eat between shifts.
Why Semaglutide
Key benefits
- Clinically proven 14.9-17.4% weight loss²
- Once-weekly injection
- Reduces hunger and cravings
- Improves metabolic health
- Well-established safety profile
Ideal for
- Those seeking a proven, cost-effective option
- Patients who prefer the most-studied GLP-1 medication
- Those with moderate weight loss goals
- Patients looking for a well-established safety profile
How Semaglutide Works
Semaglutide mimics your body's natural GLP-1 hormone to reduce appetite and promote weight loss.
01 — Step
Slows Digestion
Delays gastric emptying so food stays in your stomach longer, helping you feel full and satisfied after smaller meals.
02 — Step
Regulates Appetite
Acts on brain receptors that control hunger and satiety, reducing overall appetite and food cravings throughout the day.
03 — Step
Improves Metabolism
Enhances insulin sensitivity and helps your body process glucose more efficiently, supporting healthy weight management.
Dosing & Administration
- Administration
- Once-weekly subcutaneous injection.
- Initiation dose
- Weeks 1-4: 0.25mg weekly (initiation dose)
- Later doses
- Weeks 5-8: 0.5mg weekly Weeks 9-12: 1.0mg weekly Week 12+: 1.7-2.4mg weekly (maintenance)
- Adjustment
- Semaglutide is administered as a once-weekly subcutaneous injection. Your provider will gradually increase your dose over several weeks.
Frequently Asked Questions
Compounded versions of semaglutide are not associated with Novo Nordisk and/or its genuine OZEMPIC® and/or WEGOVY® products. Compounded versions of semaglutide are not FDA approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy. GLP-1 medications may cause serious side effects, including possible thyroid tumors, including cancer. See the "Important Safety Information" links below for more details.
More on Semaglutide
Deeper dives from our editorial team — pricing, dosing, and the research behind it.
About Our Medications
Our treatments contain active pharmaceutical ingredients that conform to USP (United States Pharmacopeia) monograph standards and are custom-compounded by licensed 503A and 503B pharmacies to meet your individual needs. Compounded medications are not FDA-approved finished drug products. The suggested formulations are provided for reference only and are based on formulations that have historically been prescribed by duly licensed prescribers. All medications are prepared in accordance with a valid prescription from a licensed healthcare provider following a medical consultation.
Medical Consultation Required
Our licensed medical providers will evaluate your health history and goals to determine the most appropriate treatment option for you. Prescriptions are subject to medical evaluation and are not guaranteed. If we are unable to prescribe treatment after your consultation, you pay zero. Independent clinical services provided by: Wasef Health, PC c/o Michael Wasef MD. Licensed in all 50 states + DC.
Clinical References
- 1Wilding JPH, et al. STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
- 2Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS, Koopman R. Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice. Clinical Nutrition. 2016;35(5):1118–1126.
- 3Caldow MK, Ham DJ, Chee A, Trieu J, Naim T, Stapleton DI, Swiderski K, Lynch GS, Koopman R. Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling. Frontiers in Nutrition. 2019;6:172.
- 4Ham DJ, Gleeson BG, Chee A, Baum DM, Caldow MK, Lynch GS, Koopman R. L-Glycine Restores the Anabolic Response to Leucine in a Mouse Model of Acute Inflammation. American Journal of Physiology - Endocrinology and Metabolism. 2016;310(11):E970–E981.